Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer

Breast Cancer Research and Treatment

Volumn 58, Issue 3, 1999, Pages 267-280

  Ward, Bryan K ^a   Mark, Peter J ^a,b   Ingram, David M ^c   Minchin, Rodney F ^b   Ratajczak, Thomas ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Mount Medical Center   (Australia)

Author keywords

Breast cancer; Estrogen receptor; Expression; Immunophilins

Indexed keywords

CYCLOPHILIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FKBP 52; IMMUNOPHILIN; MESSENGER RNA; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033490140     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1006390804515     Document Type: Article

References (57)

1. 1. Ciocca DR, Fanelli MA: Estrogen receptors and cell proliferation in breast cancer. TEM 8: 313-321, 1997
2. 2. McGuire WL, Chamness GC, Fuqua SAW: Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5: 1571-1577, 1991
3. 3. Henderson BE, Ross RK, Pike MC: Toward the primary prevention of cancer. Science 254: 1131-1138, 1991
4. 4. Bocchinfuso WP, Couse JF, Hively WP, Varmus HE, Korach KS: Hormonal signaling pathways in mammary glands of ERKO/Wnt-I mice (Abstract 0R40-4). In: Proceedings of the 80th Annual Meeting of The Endocrine Society, New Orleans, Louisiana, 1998
5. 5. Pratt WB, Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrin Revs 18: 306-360, 1997
6. 6. Gething M-J, Sambrook J: Protein folding in the cell. Nature 355: 33-45, 1992
7. 7. Fruman DA, Burakoff SJ, Bierer BE: Imunophilins in protein folding and immunosuppression. FASEB J 8: 391-400, 1994
8. 8. Bose S, Weikl T, Bügl H, Buchner J: Chaperone function of hsp90-associated proteins. Science 274: 1715-1717, 1996
9. 9. Freeman BC, Toft DO, Morimoto RI: Molecular chaperone machines: chaperone activities of the cyclophilin cyp-40 and the steroid aporeceptor-associated protein p23. Science 274: 1718-1720, 1996
10. 10. Sanchez ER: Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J Biol Chem 265: 22067-22070, 1990
11. 11. Weisman R, Creanor J, Fantes P: A multicopy suppressor of a cell cycle defect in S. pombe encodes a heat shock-inducible 40 kDa cyclophilin-like protein EMBO J 15: 447-456, 1996
12. 12. Warth R, Briand P-A, Picard D: Functional analysis of the yeast 40 kDa cyclophilin cyp40 and its role for viability and steroid receptor regulation. Biol Chem 378: 381-391, 1997
13. 13. Duina AA, Chang H-CJ, Marsh JA, Lindquist S, Gaber RF: A cyclophilin function in hsp90-dependent signal transduction. Science 274: 1713-1715, 1996
14. 14. Czar MJ, Lyons RH, Welsh MJ, Renoir J-M, Pratt WB: Evidence that the FK506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 9: 1549-1560, 1995
15. 15. Owens-Grillo JK, Czar MJ, Hutchison KA, Hoffmann K, Perdew GH, Pratt WB: A model of protein targeting mediated by immunophilins and other proteins that bind to hsp90 via tetratricopeptide repeat domains. J Biol Chem 271: 13468-13475, 1996
16. 16. Reynolds PD, Ruan Y, Smith DF, Scammell JG: Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrin Metab 84: 663-669, 1999
17. 17. Duina AA, Kalton HM, Gaber RF: Requirement for hsp90 and a cyp-40-type cyclophilin in negative regulation of the heat shock response. J Biol Chem 273: 18974-18978, 1998
18. 18. Doucet-Brutin S, Renoir M, LeGallic L, Vincent S, Marty L, Fort P: Growth regulated expression of FKBP-59 immunophilin in normal and transformed fibroblastic cells. Exp Cell Res 220: 152-160, 1995
19. 19. Perrot-Applanat M, Cibert C, Geraud G, Renoir J-M, Baulieu E-E: The 59 kDa FK506-binding protein, a 90 kDa heat shock protein binding immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus. J Cell Sci 108: 2037-2051, 1995
20. 20. Yeh W-C, Li T-K, Bierer BE, McKnight SL: Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation. Proc Natl Acad Sci USA 92: 11081-11085, 1995
21. 21. Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL: Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13: 3577-3587, 1993
22. 22. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991
23. 23. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, New York, 1989
24. 24. Ratajczak T, Mark PJ, Martin RF, Minchin RF: Cyclosporin A potentiates estradiol-induced expression of the cathepsin D gene in MCF7 breast cancer cells. Biochem Biophys Res Commun 220: 208-212, 1996
25. 25. Ratajczak T, Carrello A, Mark PJ, Warner BJ, Simpson RJ, Moritz RL, House AK: The cyclophilin component of the unactivated estrogen receptor contains a tetratricopeptide repeat domain and shares identity with p59 (FKBP59). J Biol Chem 268: 13187-13192, 1993
26. 26. Peattie DA, Harding MW, Fleming MA, DeCenzo MT, Lippke JA, Livingston DJ, Benasutti M: Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc Natl Acad Sci USA 89: 10974-10978, 1992
27. 27. Katz RA, Erlanger BF, Guntaka RV: Evidence for extensive methylation of ribosomal RNA genes in a rat XC cell line. Biochim Biophys Acta 739: 258-264, 1983
28. 28. Fawell SE, White R, Hoare S, Sydenham M, Page M, Parker MG: Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87: 6883-6887, 1990
29. 29. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
30. 30. Ratajczak T, Carrello A, Minchin RF: Biochemical and calmodulin binding properties of estrogen receptor binding cyclophilin expressed in Escherichia coli. Biochem Biophys Res Commun 209: 117-125, 1995
31. 31. Kieffer LJ, Seng TW, Li W, Osterman DG, Handschumacher RE, Bayney RM: Cyclophilin-40, a protein with homology to the p59 component of the steroid receptor complex. J Biol Chem 268: 12303-12310, 1993
32. 32. Tai P-KK, Maeda Y, Nakao K, Wakim NG, Duhring JL, Faber LE: A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry 25: 5269-5275, 1986
33. 33. Chambraud B, Rouviere-Fourmy N, Radanyi C, Hsiao K, Peattie DA, Livingston DJ, Baulieu EE: Overexpression of p59-HBI (FKBP59), full length and domains, and characterization of PPlase activity. Biochem Biophys Res Commun 196: 160-166, 1993
34. 34. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P: Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucl Acids Res 10: 7895-7903, 1982
35. 35. Laborda J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucl Acids Res 19: 3998, 1991
36. 36. Kulski JK, Howard MJ, Pixley EC: DNA sequences of human papillomavirus types 11, 16 or 18 in invasive cervical carcinoma of Western Australian women. Immunol Cell Biol 65: 77-84, 1987
37. 37. Ng SY, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L: Evolution of the functional human beta-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5: 2720-2732, 1985
38. 38. Yokoi H, Shimizu Y, Anazawa H, Lefebvre CA, Korneluk RG, Ikeda J-E: The structure and complete nucleotide sequence of the human cyclophilin 40 (PPID) gene. Genomics 35: 448-455, 1996
39. 39. Nair SC, Rimerman RA, Toran EJ, Chen S, Prapapanich V, Butts RN, Smith DF: Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with hsp90 and progesterone receptor. Mol Cell Biol 17: 594-603, 1997
40. 40. Nurse P: Universal control mechanism regulating onset of M-phase. Nature 344: 503-508, 1990
41. 41. Karnik PS, Kulkarni S, Liu X-P, Budd GT, Bukowski RM: Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res 54: 349-353, 1994
42. 42. Gress TM, Müller-Pillasch F, Weber C, Lerch MM, Friess H, Buchler M, Beger HG, Adler G: Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res 54: 547-551, 1994
43. 43. Conroy SE, Latchman DS: Do heat shock proteins have a role in breast cancer? Br J Cancer 74: 717-721, 1996
44. 44. Yano M, Naito Z, Tanaka S, Asano G: Expression and roles of heat shock proteins in human breast cancer. Jap J Cancer Res 87: 908-915, 1996
45. 45. Morimoto RI: Cells in stress: transcriptional activation of heat shock genes. Science 259: 1409-1410, 1993
46. 46. Jäättelä M, Wissing D, Bauer PA, Li GC: Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J 11: 3507-3512, 1992
47. 47. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SAW: Biological and clinical implications of heat shock protein 27000 (hsp27): a review. J Natl Cancer Inst 85: 1558-1570, 1993
48. 48. Ciocca DR, Clark GM, Tandon AK, Fuqua SAW, Welch WJ, McGuire WL: Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 85: 570-574, 1993
49. 49. Buchner J: Hsp90 & Co. - a holding for folding. TIBS 24: 136-141, 1999
50. 50. Segnitz B, Gehring U: Subunit structure of the nonactivated human estrogen receptor. Proc Natl Acad Sci USA 92: 2179-2183, 1995
51. 51. Baughman G, Wiederrecht GJ, Chang F, Martin MM, Bourgeois S: Tissue distribution and abundance of human FKBP51, an FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun 232: 437-443, 1997
52. 52. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson J-Å: Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J Clin Endocrin Metab 82: 4258-4265, 1997
53. 53. Hall RE, Lee CSL, Alexander IE, Shine J, Clarke CL, Sutherland R: Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between estrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 46: 1081-1087, 1990
54. 54. Barent RL, Nair SC, Carr DC, Ruan Y, Rimerman RA, Fulton F, Zhang Y, Smith DF: Analysis of FKBP51/FKBP52 chimeras and mutants for hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol 12: 342-354, 1998
55. 55. Kay PH, Jacobsen PF, Taylor J, Spagnolo D: The significance of DNA methylation in cancer. Adv Anat Path 2: 353-361, 1995
56. 56. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-2160, 1994
57. 57. Ratajczak T, Woollatt E, Kumar P, Ward BK, Minchin RF, Baker E: Cyclophilin 40 (PPID) gene. Map position 4q31.3. Chromosome Res 5: 151, 1997